AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amiloride Hydrochloride And Hydrochlorothiazide, and when can generic versions of Amiloride Hydrochloride And Hydrochlorothiazide launch?
Amiloride Hydrochloride And Hydrochlorothiazide is a drug marketed by Barr, Chartwell Rx, Rising, Teva, and Watson Labs. and is included in five NDAs.
The generic ingredient in AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is amiloride hydrochloride; hydrochlorothiazide. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amiloride hydrochloride; hydrochlorothiazide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amiloride Hydrochloride And Hydrochlorothiazide
A generic version of AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE was approved as amiloride hydrochloride; hydrochlorothiazide by BARR on May 10th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What are the global sales for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
- What is Average Wholesale Price for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE?
Summary for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 6 |
Clinical Trials: | 12 |
Patent Applications: | 114 |
Formulation / Manufacturing: | see details |
DailyMed Link: | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at DailyMed |
![AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE drug patent expirations Drug patent expirations by year for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE](/p/graph/s/t/AMILORIDE_HYDROCHLORIDE_AND_HYDROCHLOROTHIAZIDE-patent-expirations.png)
Recent Clinical Trials for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hospital de Clinicas de Porto Alegre | Phase 3 |
Instituto de Cardiologia do Rio Grande do Sul | Phase 3 |
Guangdong General Hospital | Phase 4 |
See all AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE clinical trials
Pharmacology for AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Drug Class | Potassium-sparing Diuretic Thiazide Diuretic |
Physiological Effect | Decreased Renal K+ Excretion Increased Diuresis |